Marc E. Lenburg

Marc E. Lenburg

Auto-generated profile, based on publicly available information

Marc E. Lenburg

Section of Computational Biomedicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2015 in Aging Cell
Verified
Journal Article
Open access
PDF file
YZYi Zhu
Yi Zhu
TTTamara Tchkonia
Tamara Tchkonia
TPTamar Pirtskhalava
Tamar Pirtskhalava
AGAdam C. Gower
Adam C. Gower
HDHusheng Ding
Husheng Ding
JKJames L. Kirkland
James L. Kirkland
The healthspan of mice is enhanced by killing senescent cells using a transgenic suicide gene. Achieving the same using small molecules would have a tremendous impact on quality of life and the burden of age-related chronic diseases. Here, we describe the rationale for identification and validation of a new class of drugs termed senolytics, which selectively kill senescent cells. By transcript analysis, we discovered increased expression of pro-survival networks in senescent cells, consistent with their established resistance to apoptosis. Using siRNA to silence expression of key nodes of this network, including ephrins (EFNB1 or 3), PI3Kδ, p21, BCL-xL, or plasminogen-activated inhibitor-2, killed senescent cells, but not proliferating or quiescent, differentiated cells. Drugs targeting these same factors selectively killed senescent cells. Dasatinib eliminated senescent human fat cell progenitors, while quercetin was more effective against senescent human endothelial cells and mouse BM-MSCs. The combination of dasatinib and quercetin was effective in eliminating senescent MEFs. In vivo, this combination reduced senescent cell burden in chronologically aged, radiation-exposed, and progeroid Ercc1(-/Δ) mice. In old mice, cardiac function and carotid vascular reactivity were improved 5 days after a single dose. Following irradiation of one limb in mice, a single dose led to improved exercise capacity for at least 7 months following drug treatment. Periodic drug administration extended healthspan in Ercc1(-/∆) mice, delaying age-related symptoms and pathology, osteoporosis, and loss of intervertebral disk proteoglycans. These results demonstrate the feasibility of selectively ablating senescent cells and the efficacy of senolytics for alleviating symptoms of frailty and extending healthspan.

18 December 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
WMWilliam M. Merritt
William M. Merritt
YLYvonne G. Lin
Yvonne G. Lin
LHLiz Y. Han
Liz Y. Han
AKAparna A. Kamat
Aparna A. Kamat
WSWhitney A. Spannuth
Whitney A. Spannuth
ASAK Sood
AK Sood
We studied Dicer and Drosha, components of the RNA-interference machinery, in ovarian cancer. We measured messenger RNA (mRNA) levels of Dicer and Drosha in specimens of invasive epithelial ovarian cancer from 111 patients, using a quantitative reverse-transcriptase–polymerase-chain-reaction assay, and compared the results with clinical outcomes. Validation was performed with the use of published microarray data from cohorts of patients with ovarian, breast, and lung cancer. Mutational analyses of genomic DNA from the Dicer and Drosha genes were performed in a subgroup of ovarian-cancer specimens. Dicer-dependent functional assays were performed by means of in vitro transfection with small interfering RNA (siRNA) and short hairpin RNA (shRNA). Levels of Dicer and Drosha mRNA correlated with the levels of expression of the corresponding protein and were decreased in 60% and 51% of ovarian-cancer specimens, respectively. Low Dicer expression was significantly associated with advanced tumor stage (P=0.007), and low Drosha expression with suboptimal surgical cytoreduction (P=0.02). Cancer specimens with both high Dicer expression and high Drosha expression were associated with increased median survival (>11 years, vs. 2.66 years for other subgroups; P<0.001). We found three independent predictors of reduced disease-specific survival in multivariate analyses: low Dicer expression (hazard ratio, 2.10; P=0.02), high-grade histologic features (hazard ratio, 2.46; P=0.03), and poor response to chemotherapy (hazard ratio, 3.95; P<0.001). Poor clinical outcomes among patients with low Dicer expression were validated in additional cohorts of patients. Rare missense mutations were found in the Dicer and Drosha genes, but their presence or absence did not correlate with the level of expression. Functional assays indicated that gene silencing with shRNA, but not siRNA, may be impaired in cells with low Dicer expression. Our findings indicate that levels of Dicer and Drosha mRNA in ovarian-cancer cells have associations with outcomes in patients with ovarian cancer.

1 March 1994 in Cell
Verified
Journal Article
Closed access
CAChristopher Aiken
Christopher Aiken
JKJason A. Konner
Jason A. Konner
NLNathaniel R. Landau
Nathaniel R. Landau
MLMarc E. Lenburg
Marc E. Lenburg
DTDidier Trono
Didier Trono

14 April 2006 in Science
Verified
Journal Article
Closed access
PDF file
Alan HerbertAlan Herbert
Alan Herbert
NGNorman P. Gerry
Norman P. Gerry
MMMatthew B. McQueen
Matthew B. McQueen
IHIris M. Heid
Iris M. Heid
APArne Pfeufer
Arne Pfeufer
MCMichael F. Christman
Michael F. Christman
Obesity is a heritable trait and a risk factor for many common diseases such as type 2 diabetes, heart disease, and hypertension. We used a dense whole-genome scan of DNA samples from the Framingham Heart Study participants to identify a common genetic variant near the INSIG2 gene associated with obesity. We have replicated the finding in four separate samples composed of individuals of Western European ancestry, African Americans, and children. The obesity-predisposing genotype is present in 10% of individuals. Our study suggests that common genetic polymorphisms are important determinants of obesity.

4 March 2007 in Nature Medicine
Verified
Journal Article
Closed access
ASAvrum Spira
Avrum Spira
JBJennifer Beane
Jennifer Beane
VSVishal Shah
Vishal Shah
KSKatrina Steiling
Katrina Steiling
GLGang Liu
Gang Liu
JBJerome S Brody
Jerome S Brody

17 February 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FSFrank Schembri
Frank Schembri
SSSriram Sridhar
Sriram Sridhar
CPCatalina Perdomo
Catalina Perdomo
AGAdam M. Gustafson
Adam M. Gustafson
XZXiaoling Zhang
Xiaoling Zhang
ASAvrum Spira
Avrum Spira
We have shown that smoking impacts bronchial airway gene expression and that heterogeneity in this response associates with smoking-related disease risk. In this study, we sought to determine whether microRNAs (miRNAs) play a role in regulating the airway gene expression response to smoking. We examined whole-genome miRNA and mRNA expression in bronchial airway epithelium from current and never smokers (n= 20) and found 28 miRNAs to be differentially expressed (P< 0.05) with the majority being down-regulated in smokers. We further identified a number of mRNAs whose expression level is highly inversely correlated with miRNA expression in vivo. Many of these mRNAs contain potential binding sites for the differentially expressed miRNAs in their 3′-untranslated region (UTR) and are themselves affected by smoking. We found that either increasing or decreasing the levels of mir-218 (a miRNA that is strongly affected by smoking) in both primary bronchial epithelial cells and H1299 cells was sufficient to cause a corresponding decrease or increase in the expression of predicted mir-218 mRNA targets, respectively. Further, mir-218 expression is reduced in primary bronchial epithelium exposed to cigarette smoke condensate (CSC), and alteration of mir-218 levels in these cells diminishes the induction of the predicted mir-218 target MAFG in response to CSC. These data indicate that mir-218 levels modulate the airway epithelial gene expression response to cigarette smoke and support a role for miRNAs in regulating host response to environmental toxins.